Durable discontinuation of systemic therapy for chronic graft-<i>versus</i>-host disease: myth or reality?

Παρόμοια τεκμήρια

• Patient-reported treatment response in chronic graft-<i>versus</i>-host disease
  από: Annie Im, κ.ά.
  Έκδοση: (2023-05-01)
• The development of graft-<i>versus</i>-host disease prophylaxis
  από: Corey Cutler
  Έκδοση: (2023-03-01)
• Durable discontinuation of systemic therapy for chronic graft-<i>versus</i>-host disease: myth or reality?
  από: Steven Z. Pavletic, κ.ά.
  Έκδοση: (2022-05-01)
• Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study
  από: Joseph Pidala, κ.ά.
  Έκδοση: (2012-03-01)
• Refined National Institutes of Health response algorithm for chronic graft-versus-host disease in joints and fascia
  από: Yoshihiro Inamoto, κ.ά.
  Έκδοση: (2020-01-01)